Previous Close | 510.40 |
Open | 511.60 |
Bid | 510.00 x 0 |
Ask | 520.00 x 0 |
Day's Range | 511.60 - 521.40 |
52 Week Range | 308.60 - 599.40 |
Volume | |
Avg. Volume | 210,057 |
Market Cap | 37.068B |
Beta (5Y Monthly) | 0.63 |
PE Ratio (TTM) | 57.82 |
EPS (TTM) | 8.89 |
Earnings Date | Jul 25, 2024 |
Forward Dividend & Yield | 4.00 (0.78%) |
Ex-Dividend Date | May 13, 2024 |
1y Target Est | 715.25 |
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update.
Lonza Group ( VTX:LONN ) Full Year 2023 Results Key Financial Results Revenue: CHF6.72b (up 7.9% from FY 2022). Net...
Key Insights The considerable ownership by individual investors in Lonza Group indicates that they collectively have a...